Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02172118
What this trial is testing

BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function

Who this might be right for
Healthy
Boehringer Ingelheim 22
Not applicableStudy completedNCT00391287
What this trial is testing

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

Who this might be right for
Pure Red-Cell AplasiaChronic Kidney Failure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 15,334
Early research (Phase 1)Study completedNCT02427035
What this trial is testing

CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment

Who this might be right for
Acute Myocardial Infarction
CSL Behring 32
Testing effectiveness (Phase 2)Study completedNCT02055482
What this trial is testing

Long-term Pre-dialysis Extension in Europe and Asia Pacific

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 166
Early research (Phase 1)Study completedNCT01054261
What this trial is testing

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Who this might be right for
Renal
VIVUS LLC 24
Testing effectiveness (Phase 2)UnknownNCT04445220
What this trial is testing

Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy

Who this might be right for
COVID-19Acute Kidney InjurySepsis
Sentien Biotechnologies, Inc. 22
Large-scale testing (Phase 3)Study completedNCT01382212
What this trial is testing

Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis

Who this might be right for
End-Stage Renal DiseaseSecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 13
Early research (Phase 1)Study completedNCT01419041
What this trial is testing

Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Pfizer 16
Large-scale testing (Phase 3)Study completedNCT02648347
What this trial is testing

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Who this might be right for
AnemiaNon-Dialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 1,751
Early research (Phase 1)WithdrawnNCT02325024
What this trial is testing

Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.

Who this might be right for
Renal InsufficiencyKidney Disease
GW Pharmaceuticals Ltd
Early research (Phase 1)Study completedNCT00596518
What this trial is testing

Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

Who this might be right for
Renal Insufficiency, Chronic
Pfizer 30
Early research (Phase 1)Study completedNCT00483860
What this trial is testing

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

Who this might be right for
Solid Tumours
GlaxoSmithKline 59
Early research (Phase 1)Study completedNCT05374343
What this trial is testing

The Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 32
Early research (Phase 1)Ended earlyNCT01406340
What this trial is testing

Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment

Who this might be right for
Anaemia
GlaxoSmithKline 22
Testing effectiveness (Phase 2)Study completedNCT02603614
What this trial is testing

Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment

Who this might be right for
Heart FailureRenal Insufficiency
Capricor Inc. 8
Large-scale testing (Phase 3)Ended earlyNCT05342623
What this trial is testing

Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 286
Early research (Phase 1)Study completedNCT05673603
What this trial is testing

Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Who this might be right for
Renal Impairment
Insmed Incorporated 28
Testing effectiveness (Phase 2)Study completedNCT03131479
What this trial is testing

Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 53
Early research (Phase 1)Study completedNCT03690362
What this trial is testing

VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment

Who this might be right for
Pharmacokinetics
Venatorx Pharmaceuticals, Inc. 33
Early research (Phase 1)Study completedNCT02110459
What this trial is testing

Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment

Who this might be right for
Renal Impairment
Polyphor Ltd. 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation